{"title": "Genome editing reduces cholesterol in large animal model, laying human trial groundwork", "title_detail": {"type": "text/plain", "language": null, "base": "https://www.sciencedaily.com/rss/health_medicine/gene_therapy.xml", "value": "Genome editing reduces cholesterol in large animal model, laying human trial groundwork"}, "links": [{"rel": "alternate", "type": "text/html", "href": "https://www.sciencedaily.com/releases/2018/07/180709111142.htm"}], "link": "https://www.sciencedaily.com/releases/2018/07/180709111142.htm", "summary": "Using genome editing to inactivate a protein called PCSK9 effectively reduced cholesterol levels in rhesus macaques. This is the first demonstration of a clinically relevant reduction of gene expression in a large animal model using genome editing. The study describes a possible new approach for treating heart disease patients who do not tolerate PCSK9 inhibitors -- drugs that are commonly used to combat high cholesterol.", "summary_detail": {"type": "text/html", "language": null, "base": "https://www.sciencedaily.com/rss/health_medicine/gene_therapy.xml", "value": "Using genome editing to inactivate a protein called PCSK9 effectively reduced cholesterol levels in rhesus macaques. This is the first demonstration of a clinically relevant reduction of gene expression in a large animal model using genome editing. The study describes a possible new approach for treating heart disease patients who do not tolerate PCSK9 inhibitors -- drugs that are commonly used to combat high cholesterol."}, "published": "Mon, 09 Jul 2018 11:11:42 EDT", "published_parsed": [2018, 7, 9, 15, 11, 42, 0, 190, 0], "id": "https://www.sciencedaily.com/releases/2018/07/180709111142.htm", "guidislink": false}